Tower Research Capital LLC (Trc) Kezar Life Sciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,886 shares of KZR stock, worth $74,145. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,886
Previous 23,064 57.14%
Holding current value
$74,145
Previous $13,000 46.15%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.53 - $0.77 $6,984 - $10,147
-13,178 Reduced 57.14%
9,886 $7,000
Q2 2024

Aug 13, 2024
BUY
$0.6 - $0.92 $9,918 - $15,208
16,531 Added 253.04%
23,064 $13,000
Q1 2024

May 15, 2024
SELL
$0.8 - $1.05 $3,957 - $5,194
-4,947 Reduced 43.09%
6,533 $5,000
Q4 2023

Feb 13, 2024
BUY
$0.72 - $1.15 $725 - $1,159
1,008 Added 9.63%
11,480 $10,000
Q3 2023

Nov 14, 2023
SELL
$1.08 - $2.54 $17,829 - $41,932
-16,509 Reduced 61.19%
10,472 $12,000
Q2 2023

Aug 14, 2023
BUY
$2.31 - $3.06 $19,110 - $25,315
8,273 Added 44.22%
26,981 $66,000
Q1 2023

May 09, 2023
BUY
$3.13 - $7.31 $55,028 - $128,517
17,581 Added 1559.98%
18,708 $59,000
Q4 2022

Feb 10, 2023
SELL
$6.39 - $8.8 $36,103 - $49,720
-5,650 Reduced 83.37%
1,127 $8,000
Q3 2022

Nov 10, 2022
BUY
$7.99 - $10.75 $25,488 - $34,292
3,190 Added 88.93%
6,777 $58,000
Q2 2022

Aug 15, 2022
SELL
$4.58 - $17.13 $13,854 - $51,818
-3,025 Reduced 45.75%
3,587 $30,000
Q1 2022

May 12, 2022
BUY
$12.3 - $18.33 $23,345 - $34,790
1,898 Added 40.26%
6,612 $110,000
Q4 2021

Feb 14, 2022
BUY
$7.44 - $16.72 $8,957 - $20,130
1,204 Added 34.3%
4,714 $79,000
Q3 2021

Nov 15, 2021
SELL
$4.85 - $9.73 $5,364 - $10,761
-1,106 Reduced 23.96%
3,510 $31,000
Q2 2021

Aug 16, 2021
BUY
$4.93 - $6.46 $10,929 - $14,321
2,217 Added 92.41%
4,616 $25,000
Q1 2021

May 17, 2021
SELL
$5.24 - $6.99 $74,649 - $99,579
-14,246 Reduced 85.59%
2,399 $14,000
Q4 2020

Feb 16, 2021
SELL
$4.77 - $6.58 $67,538 - $93,166
-14,159 Reduced 45.96%
16,645 $86,000
Q3 2020

Nov 16, 2020
BUY
$4.36 - $5.5 $107,238 - $135,278
24,596 Added 396.2%
30,804 $149,000
Q2 2020

Aug 13, 2020
BUY
$3.6 - $7.75 $22,348 - $48,112
6,208 New
6,208 $32,000
Q4 2019

Feb 07, 2020
SELL
$2.5 - $4.26 $3,177 - $5,414
-1,271 Closed
0 $0
Q3 2019

Nov 05, 2019
BUY
$3.0 - $7.58 $3,684 - $9,308
1,228 Added 2855.81%
1,271 $4,000
Q2 2019

Aug 13, 2019
SELL
$7.09 - $21.9 $12,173 - $37,602
-1,717 Reduced 97.56%
43 $0
Q1 2019

May 14, 2019
BUY
$16.83 - $23.75 $27,870 - $39,330
1,656 Added 1592.31%
1,760 $31,000
Q4 2018

Feb 14, 2019
BUY
$20.21 - $32.9 $2,101 - $3,421
104 New
104 $2,000

Others Institutions Holding KZR

# of Institutions
61
Shares Held
38.4M
Call Options Held
13.8K
Put Options Held
600
View Full List

About Kezar Life Sciences, Inc.

KZR Quotes by TradingView
  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $513M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email